For: | Vivarelli M, Montalti R, Risaliti A. Multimodal treatment of hepatocellular carcinoma on cirrhosis: An update. World J Gastroenterol 2013; 19(42): 7316-7326 [PMID: 24259963 DOI: 10.3748/wjg.v19.i42.7316] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i42/7316.htm |
Number | Citing Articles |
1 |
Edris M. Alkozai, Robert J. Porte, Jelle Adelmeijer, Alberto Zanetto, Paolo Simioni, Marco Senzolo, Ton Lisman. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma. Platelets 2015; 26(6): 577 doi: 10.3109/09537104.2014.961415
|
2 |
Ahmet Gurakar, Serkan Dogan. Liver Transplantation Update: 2014. Euroasian Journal of Hepato-Gastroenterology 2015; 5(2): 98 doi: 10.5005/jp-journals-10018-1144
|
3 |
Stefanie J. Hectors, Sara Lewis, Paul Kennedy, Octavia Bane, Daniela Said, Maxwell Segall, Myron Schwartz, Edward Kim, Bachir Taouli. Assessment of Hepatocellular Carcinoma Response to 90Y Radioembolization Using Dynamic Contrast Material–enhanced MRI and Intravoxel Incoherent Motion Diffusion-weighted Imaging. Radiology: Imaging Cancer 2020; 2(4): e190094 doi: 10.1148/rycan.2020190094
|
4 |
Dario Lorenzin, Riccardo Pravisani, Cosimo Alex Leo, Walter Bugiantella, Giorgio Soardo, Alessia Carnelutti, Baccarani Umberto, Andrea Risaliti. Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization. Cancer Biotherapy and Radiopharmaceuticals 2016; 31(2): 65 doi: 10.1089/cbr.2015.1905
|
5 |
Concetta Panebianco, Chiara Saracino, Valerio Pazienza. Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression. Tumor Biology 2014; 35(8): 7307 doi: 10.1007/s13277-014-2075-x
|
6 |
Sirkka Buitkamp, Stephanie Schwalm, Katja Jakobi, Nerea Ferreiros, Christin Wünsche, Stefan Zeuzem, Erich Gulbins, Christoph Sarrazin, Josef Pfeilschifter, Georgios Grammatikos. Acid Sphingomyelinase Activation and ROS Generation Potentiate Antiproliferative Effects of Mitomycin in HCC. International Journal of Molecular Sciences 2024; 25(22): 12175 doi: 10.3390/ijms252212175
|
7 |
Huanan Li, Yong Sun, Jie Liang, Yujiang Fan, Xingdong Zhang. pH-Sensitive pullulan–DOX conjugate nanoparticles for co-loading PDTC to suppress growth and chemoresistance of hepatocellular carcinoma. Journal of Materials Chemistry B 2015; 3(41): 8070 doi: 10.1039/C5TB01210D
|
8 |
Yan Sun, Hai Sun. Retracted:Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5. Journal of Cellular Physiology 2020; 235(3): 2963 doi: 10.1002/jcp.29202
|
9 |
Akanksha Dubey, Jayanthi Sivaraman. Comparative Therapeutic Approaches for Hepatocellular Carcinoma-A Concise Review. Research Journal of Pharmacy and Technology 2023; : 4447 doi: 10.52711/0974-360X.2023.00726
|
10 |
Abdifatah Jalei, Abdifetah Omar, Shafie Hassan, Yahye Hassan, Nur Ahmed. Establishment of Reference Intervals for Common Renal and Liver Function Parameters in Healthy Adults in Mogadishu, Somalia: A Cross-Sectional Study. International Journal of General Medicine 2024; : 4163 doi: 10.2147/IJGM.S480478
|
11 |
Xin Wang, Xinyi Casuarine Low, Weixin Hou, Lissa Nurrul Abdullah, Tan Boon Toh, Masturah Mohd Abdul Rashid, Dean Ho, Edward Kai-Hua Chow. Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells. ACS Nano 2014; 8(12): 12151 doi: 10.1021/nn503491e
|
12 |
Sonja Gordic, Mathilde Wagner, Riccardo Zanato, Stefanie Hectors, Cecilia Besa, Shingo Kihira, Edward Kim, Bachir Taouli. Prediction of hepatocellular carcinoma response to 90Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results. Cancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0216-6
|
13 |
Sidrah Khan, Alexis Chidi, Katherine Hrebinko, Christof Kaltenmeier, Ibrahim Nassour, Richard Hoehn, David Geller, Allan Tsung, Samer Tohme. Readmission After Surgical Resection and Transplantation for Hepatocellular Carcinoma: A Retrospective Cohort Study. The American Surgeon™ 2022; 88(1): 83 doi: 10.1177/0003134820973739
|
14 |
Abdulrahman Ahmed Mahmood, Jianqi Zhang, Rufang Liao, Xiwei Pan, Dan Xu, Haibo Xu, Qibing Zhou. Evaluation of non-targeting, C- or N-pH (low) insertion peptide modified superparamagnetic iron oxide nanoclusters for selective MRI of liver tumors and their potential toxicity in cirrhosis. RSC Advances 2019; 9(25): 14051 doi: 10.1039/C9RA02430A
|
15 |
Hong-xiang Huang, Pei-yuan Zhong, Ping Li, Su-juan Peng, Xin-jing Ding, Xiang-lian Cai, Jin-hong Chen, Xie Zhu, Zhi-hui Lu, Xing-yu Tao, Yang-yang Liu, Li Chen. Development and Validation of a Carbohydrate Metabolism-Related Model for Predicting Prognosis and Immune Landscape in Hepatocellular Carcinoma Patients. Current Medical Science 2024; 44(4): 771 doi: 10.1007/s11596-024-2886-y
|
16 |
Xiaolei Zhang, Shuang Liu, Congle Shen, Yali Wu, Ling Zhang, Xiangmei Chen, Fengmin Lu. DNA Methylation Consistency Implicates the Primary Tumor Cell Origin of Recurrent Hepatocellular Carcinoma. Epigenomics 2015; 7(4): 581 doi: 10.2217/epi.15.23
|
17 |
Lisha Mou, Zuhui Pu, Yongxiang Luo, Ryan Quan, Yunhu So, Hui Jiang. Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1036562
|
18 |
Madhukar S. Patel, Rachel Kohn, Johannes R. Kratz, Jigesh A. Shah, James F. Markmann, Parsia A. Vagefi. The Race to Liver Transplantation: A Comparison of Patients With and Without Hepatocellular Carcinoma from Listing to Post-Transplantation. Journal of the American College of Surgeons 2015; 220(6): 1001 doi: 10.1016/j.jamcollsurg.2014.12.050
|
19 |
Xiuya Hu, Peiyu Zhang, Sai Li, Jiaqi Zhang, Danni Wang, Zihan Wang, Lu Zhu, Lingdi Wang. Mitochondrial GCN5L1 acts as a novel regulator for iron homeostasis to promote sorafenib sensitivity in hepatocellular carcinoma. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05404-3
|
20 |
LEVAN BENASHVILI, TAMAR TURMANIDZE, EVGENI ASATIANI. ROLE OF DIABETES AND NONALCOHOLIC FATTY LIVER DISEASE FOR HCC DEVELOPMENT. EXPERIMENTAL & CLINICAL MEDICINE GEORGIA 2022; doi: 10.52340/jecm.2022.717
|
21 |
Juliane Schelhorn, Jan Best, Marcus P. Reinboldt, Alexander Dechêne, Guido Gerken, Marcus Ruhlmann, Thomas C. Lauenstein, Gerald Antoch, Sonja Kinner. Does diffusion‐weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd‐EOB‐DTPA with and without DWI. Journal of Magnetic Resonance Imaging 2015; 42(3): 818 doi: 10.1002/jmri.24827
|
22 |
YULIANG WANG, YINLONG WANG, HONG MU, TAO LIU, XIAOBO CHEN, ZHONGYANG SHEN. Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells. Molecular Medicine Reports 2015; 11(5): 3361 doi: 10.3892/mmr.2015.3239
|
23 |
Marco Le Grazie, Maria Rosa Biagini, Mirko Tarocchi, Simone Polvani, Andrea Galli. Chemotherapy for hepatocellular carcinoma: The present and the future. World Journal of Hepatology 2017; 9(21): 907-920 doi: 10.4254/wjh.v9.i21.907
|
24 |
Fan Zhang, Jun Yan, Xiao-Bin Feng, Feng Xia, Xiao-Wu Li, Kuan-Sheng Ma, Ping Bie. Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort study. World Journal of Gastroenterology 2015; 21(35): 10159-10165 doi: 10.3748/wjg.v21.i35.10159
|
25 |
Li Zhen, Ning Shijie, Zhang Shuijun. Tumor PHD2 Expression Is Correlated With Clinical Features and Prognosis of Patients With HCC Receiving Liver Resection. Medicine 2014; 93(29): e179 doi: 10.1097/MD.0000000000000179
|
26 |
Kazuhiro Ezaka, Mitsuro Kanda, Hiroyuki Sugimoto, Dai Shimizu, Hisaharu Oya, Shuji Nomoto, Satoshi Sueoka, Yuri Tanaka, Hideki Takami, Ryoji Hashimoto, Yukiyasu Okamura, Suguru Yamada, Tsutomu Fujii, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy. Annals of Surgical Oncology 2015; 22(S3): 1499 doi: 10.1245/s10434-015-4695-9
|
27 |
|
28 |
Yifeng Tao, Feng Lin, Ruidong Li, Jie Shen, Zhengxin Wang. Prolyl hydroxylase-2 inhibits liver tumor cell proliferation and cyclin D1 expression in a hydroxylase-dependent manner. The International Journal of Biochemistry & Cell Biology 2016; 77: 129 doi: 10.1016/j.biocel.2016.05.022
|
29 |
Rafael FERNANDES-FERREIRA, Graciele Domitila TENANI, Marcela Augusta de Souza PINHEL, Ana Margarida Coelho ABRANTES, Maria Filomena Rabaça Roque BOTELHO, Rita de Cássia Martins Alves da SILVA, Dorotéia Rossi Silva SOUZA, Renato Ferreira da SILVA. GENES EXPRESSION AND SERUM BIOMARKERS FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA, CIRRHOSIS AND HEPATITIS C. Arquivos de Gastroenterologia 2022; 59(3): 394 doi: 10.1590/s0004-2803.202203000-71
|
30 |
Satoshi Sueoka, Mitsuro Kanda, Hiroyuki Sugimoto, Dai Shimizu, Shuji Nomoto, Hisaharu Oya, Hideki Takami, Kazuhiro Ezaka, Ryoji Hashimoto, Yuri Tanaka, Yukiyasu Okamura, Suguru Yamada, Tsutomu Fujii, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma. Annals of Surgical Oncology 2015; 22(S3): 1453 doi: 10.1245/s10434-015-4524-1
|
31 |
Chinmay Das, Chanakya Nath Kundu. Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects. Critical Reviews in Microbiology 2025; : 1 doi: 10.1080/1040841X.2025.2461045
|
32 |
Liping Luo, Ronghua Yan, Qingjing Zeng, Yinglin Long, Xuqi He, Kai Li, Erjiao Xu. Radiofrequency Ablation of Hepatocellular Carcinomas Adjacent to the Gallbladder Without Isolation Under Contrast-Enhanced Ultrasound Monitoring: A Comparative Study with Long Term Follow-Up. Journal of Hepatocellular Carcinoma 2023; : 631 doi: 10.2147/JHC.S388738
|
33 |
Xiaomeng Xie, Mingjie Yao, Xiangmei Chen, Weiquan Lu, Quanjun Lv, Kaijuan Wang, Ling Zhang, Fengmin Lu. Reduced Red Blood Cell Count Predicts Poor Survival After Surgery in Patients With Primary Liver Cancer. Medicine 2015; 94(8): e577 doi: 10.1097/MD.0000000000000577
|
34 |
Dashuai Yang, Yang Su, Fangrui Zhao, Chen Chen, Kailiang Zhao, Xiangyun Xiong, Youming Ding. A Practical Nomogram and Risk Stratification System Predicting Cancer-Specific Survival for Hepatocellular Carcinoma Patients With Severe Liver Fibrosis. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.920589
|
35 |
Omeralfarouk H Mohammed, Abubakr Ali M Humidan, Almegdad S Ahmed, Sharwany S Ahmed, Rami F Ibrahim , Malaz Abusefian Elbagir Omer, Muaz Hassan, Mosab Hussen Mostafa Adam, Abdallah M Ali, Shakir Mohamed, Omer H Salim. Efficacy of Antibiotic Therapy Alone Versus Antibiotics With Percutaneous Drainage in Periappendiceal Abscess: A Systematic Review and Meta-Analysis. Cureus 2024; doi: 10.7759/cureus.73979
|
36 |
Nam-Chul Jung, Jun-Ho Lee, Hyun-Ji Choi, Sung-Uk Hwang, Jie-Young Song, Han Geuk Seo, Jinjung Choi, Sang Youn Jung, Sung Gu Han, Dae-Seog Lim. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice. Immunological Investigations 2016; 45(6): 553 doi: 10.1080/08820139.2016.1183025
|
37 |
Clara Tan-Tam, Stephen W Chung. Minireview on laparoscopic hepatobiliary and pancreatic surgery. World Journal of Gastrointestinal Endoscopy 2014; 6(3): 60-67 doi: 10.4253/wjge.v6.i3.60
|